ConductScience.org, home

Paper40682115

SNRPB/CCNB1 axis promotes hepatocellular carcinoma progression and cisplatin resistance through enhancing lipid metabolism reprogramming.

Jin X and 12 others. J Exp Clin Cancer Res, 2025. Cited by 8 papers, by iCite.

Cite this record

ConductScience Library. SNRPB/CCNB1 axis promotes hepatocellular carcinoma progression and cisplatin resistance through enhancing lipid metabolism reprogramming. Papers, record 40682115. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40682115

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
SNRPB/CCNB1 axis promotes hepatocellular carcinoma progression and cisplatin resistance through enhancing lipid metabolism reprogramming.
PubMed
Journal
J Exp Clin Cancer Res
PubMed
Year
2025
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
8
iCite
Relative citation ratio, by iCite
2.13, provisional
iCite
Revised in PubMed
2025-07-22
PubMed

Authors13

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Jin XXin
2He XXigan
3Huang RRunze
4Liu QQinyu
5Wang LLei
6Bai XXuanci
7Wu YYibin
8Wang YYixiu
9Jiang ZZiting
10Shi YYi
11Sethi GGautam
12Wang LLu
13Zhu WWeiping

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Carcinoma, HepatocellularMajor topic
Liver NeoplasmsMajor topic
CisplatinMajor topic
Drug Resistance, NeoplasmMajor topic
Lipid MetabolismMajor topic
Cyclin B1Major topic
Humans
Animals
Mice
Disease Progression
Cell Line, Tumor
Cell Proliferation
Forkhead Box Protein M1
Gene Expression Regulation, Neoplastic
Male
Metabolic Reprogramming

Source PubMed

Download CSV of topics

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
2022YFE0125300National Key Research and Development Plan of the Ministry of Science and TechnologyPubMed
22ZR1413300Shanghai Natural Science Foundation ProjectPubMed
202240240the Public Health Bureau Foundation of ShanghaiPubMed

Source PubMed

Download CSV of grants

References58

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
120661013Arginase-1: a new immunohistochemical marker of hepatocytes and hepatocellular neoplasms.Am J Surg Pathol2010https://conductscience.org/library/papers/20661013PubMed
236878933CD36+ cancer-associated fibroblasts provide immunosuppressive microenvironment for hepatocellular carcinoma via secretion of macrophage migration inhibitory factor.Cell Discov2023https://conductscience.org/library/papers/36878933PubMed
333281098Fat and Furious: Lipid Metabolism in Antitumoral Therapy Response and Resistance.Trends Cancer2021https://conductscience.org/library/papers/33281098PubMed
433824478α-Fetoprotein mRNA in situ hybridisation is a highly specific marker of hepatocellular carcinoma: a multi-centre study.Br J Cancer2021https://conductscience.org/library/papers/33824478PubMed
537758792A pancancer analysis of the oncogenic role of cyclin B1 (CCNB1) in human tumors.Sci Rep2023https://conductscience.org/library/papers/37758792PubMed
632332754Accurate estimation of cell composition in bulk expression through robust integration of single-cell information.Nat Commun2020https://conductscience.org/library/papers/32332754PubMed
735262876CCNB1, Negatively Regulated by miR-559, Promotes the Proliferation, Migration, and Invasion of Ovarian Carcinoma Cells.Mol Biotechnol2022https://conductscience.org/library/papers/35262876PubMed
835229723SIRPγ-expressing cancer stem-like cells promote immune escape of lung cancer via Hippo signaling.J Clin Invest2022https://conductscience.org/library/papers/35229723PubMed
932106364SNRPB promotes cervical cancer progression through repressing p53 expression.Biomed Pharmacother2020https://conductscience.org/library/papers/32106364PubMed
1028514441PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity.Nature2017https://conductscience.org/library/papers/28514441PubMed
1138572751Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.CA Cancer J Clin2024https://conductscience.org/library/papers/38572751PubMed
1236400469Hepatocellular Carcinoma: New Developments.Clin Liver Dis2023https://conductscience.org/library/papers/36400469PubMed
1332372477Highly upregulated in liver cancer (HULC): An update on its role in carcinogenesis.J Cell Physiol2020https://conductscience.org/library/papers/32372477PubMed
1437584444Defects of the spliceosomal gene SNRPB affect osteo- and chondro-differentiation.FEBS J2024https://conductscience.org/library/papers/37584444PubMed
1536192773ACSL3 regulates lipid droplet biogenesis and ferroptosis sensitivity in clear cell renal cell carcinoma.Cancer Metab2022https://conductscience.org/library/papers/36192773PubMed
1629420223Oxidative Phosphorylation as an Emerging Target in Cancer Therapy.Clin Cancer Res2018https://conductscience.org/library/papers/29420223PubMed
1738772352Hepatocellular Carcinoma: Prevention, Diagnosis, and Treatment.Med Princ Pract2024https://conductscience.org/library/papers/38772352PubMed
1829784041Lipid metabolism reprogramming and its potential targets in cancer.Cancer Commun (Lond)2018https://conductscience.org/library/papers/29784041PubMed
1936601001CCNB1 and AURKA are critical genes for prostate cancer progression and castration-resistant prostate cancer resistant to vinblastine.Front Endocrinol (Lausanne)2022https://conductscience.org/library/papers/36601001PubMed
2036924123Management of hepatocellular carcinoma in China: Seeking common grounds while reserving differences.Clin Mol Hepatol2023https://conductscience.org/library/papers/36924123PubMed

See all 58 referencesDownload CSV of references

Cited by8

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.

PMIDTitleJournalYearIn PapersSource
42919977Rosmarinic acid combined with cisplatin induces proliferation inhibition of hepatocellular carcinoma.Naunyn Schmiedebergs Arch Pharmacol2026https://conductscience.org/library/papers/42919977PubMed
42524197A Prognostic Risk Model for Hepatocellular Carcinoma Integrating Ferroptosis and Metabolic Reprogramming Signatures.J Cancer2026https://conductscience.org/library/papers/42524197PubMed
42310288Targeting STAT3-mediated lipid metabolism reprogramming overcomes chemoresistance in acute myeloid leukemia.Cell Death Dis2026https://conductscience.org/library/papers/42310288PubMed
42292467Study of JCAD for prognosis and immune infiltration in hepatocellular carcinoma.Front Immunol2026https://conductscience.org/library/papers/42292467PubMed
41943830Mechanistic Insights into the FOXM1/BUB1 axis-Mediated Oncogenic Signaling in Hepatocellular Carcinoma.Int J Biol Sci2026https://conductscience.org/library/papers/41943830PubMed
41815139Causal relationship between metabolic syndrome and gastric cancer: insights from comprehensive analysis and biomarker identification.Transl Cancer Res2026https://conductscience.org/library/papers/41815139PubMed
41417218Deciphering the mechanism of aristolochic acid I-driven hepatocellular carcinoma through integrated network toxicology and bioinformatics.Naunyn Schmiedebergs Arch Pharmacol2026https://conductscience.org/library/papers/41417218PubMed
41099846Integrated bioinformatics and molecular docking ıdentify CCNB1, CDK1, and CYP1A2 as therapeutic targets of phytochemicals in hepatocellular carcinoma.Naunyn Schmiedebergs Arch Pharmacol2026https://conductscience.org/library/papers/41099846PubMed

Download CSV of cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CCNB1891PubTator's text mininghttps://conductscience.org/library/genes/891NCBI Gene
FOXM12305PubTator's text mininghttps://conductscience.org/library/genes/2305NCBI Gene
SNRPB6628PubTator's text mininghttps://conductscience.org/library/genes/6628NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40682115

GET https://conductscience.org/api/papers/v1/40682115/references?page=2